High Efficacy of Dupilumab in Omalizumab-Refractory Severe Chronic Spontaneous Urticaria and Delayed Pressure Urticaria

被引：0
|
作者：
Pastor-Nieto, M. A. [1 ,2 ,3 ,4 ,5 ]
Gatica-Ortega, M. E. [4 ]
机构：
[1] Hosp Univ Fdn Jimenez Diaz, Serv Dermatol, Madrid, Spain
[2] Hosp Univ Guadalajara, Serv Dermatol, Guadalajara, Madrid, Spain
[3] Univ Alcala, Fac Med & Ciencias Salud, Dept Med & Especial Med, Alcala De Henares, Spain
[4] Univ Castilla La Mancha, Albacete, Spain
[5] Complejo Hospitalario Univ Toledo, Serv Dermatol, Toledo, Spain
来源：
ACTAS DERMO-SIFILIOGRAFICAS | 2025年 / 116卷 / 02期
关键词：
D O I：
10.1016/j.ad.2023.07.038
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：191 / 193
页数：3
相关论文
共 50 条
  • [1] Cyclosporine for omalizumab-refractory chronic urticaria: a report of five cases
    Anthony F. LaCava
    Olajumoke O. Fadugba
    Allergy, Asthma & Clinical Immunology, 19
  • [2] Cyclosporine for omalizumab-refractory chronic urticaria: a report of five cases
    Lacava, Anthony F.
    Fadugba, Olajumoke O.
    ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2023, 19 (01):
  • [3] Prevalence of omalizumab-resistant chronic urticaria and real-world effectiveness of dupilumab in patients with omalizumab-refractory chronic urticaria: a single-centre experience
    Zhu, Catherine
    BinJadeed, Hessah
    Gabrielli, Sofianne
    Prosty, Connor
    Rahme, Elham
    Shand, Greg
    Fein, Michael
    Ben-Shoshan, Moshe
    Netchiporouk, Elena
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2024, 49 (10) : 1227 - 1231
  • [4] THE CONUNDRUM OF DISABLING SEVERE DELAYED PRESSURE URTICARIA AND THE EFFICACY OF OMALIZUMAB
    Rupprecht, C.
    Relangi, S.
    Rana, D.
    Haque, A.
    Krishnaswamy, G.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2023, 131 (05) : S131 - S131
  • [5] Efficacy of omalizumab in chronic spontaneous urticaria associated with chronic inducible urticaria
    Dortas Junior, Sergio
    Azizi, Guilherme
    Valle, Solange
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2020, 125 (04) : 486 - 487
  • [6] Management of severe chronic spontaneous urticaria with omalizumab
    Zubiaga Fernandez, Laura
    de Guzman Cejudo, Julia Rodriguez
    Bartra, Joan
    Ferrer, Marta
    Torres Jaen, Maria
    Testera Montes, Almudena
    Rondon Segovia, Carmen
    Perez Sanchez, Natalia
    Eguiluz, Ibon
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : AB69 - AB69
  • [7] OMALIZUMAB THERAPY FOR TREATMENT OF REFRACTORY CHRONIC SPONTANEOUS URTICARIA
    Trivedi, Amruta
    Katelaris, Constance
    INTERNAL MEDICINE JOURNAL, 2019, 49 : 32 - 33
  • [8] Efficacy and safety of omalizumab in Japanese and Korean patients with refractory chronic spontaneous urticaria
    Michihiro, Hide
    Hae-Sim, Park
    Atsuyuki, Igarashi
    Young-Min, Ye
    Tae-Bum, Kim
    Akiko, Yagami
    Jooyoung, Roh
    Jae-Hyun, Lee
    Yuko, Chinuki
    Woong, Youn Sang
    Soo-Keol, Lee
    Naoko, Inomata
    Jeong-Hee, Choi
    Atsushi, Fukunaga
    Junyi, Wang
    Soichiro, Matsushima
    Steve, Greenberg
    Sam, Khalil
    JOURNAL OF DERMATOLOGICAL SCIENCE, 2017, 87 (01) : 70 - 78
  • [9] Chronic spontaneous urticaria (CSU) associated with chronic inducible urticaria (CIndU): Efficacy of omalizumab
    Valle, S. O. R.
    Azizi, G. G.
    Dortas Junior, S. D.
    ALLERGY, 2019, 74 : 610 - 610
  • [10] OMALIZUMAB IN THE TREATMENT OF SEVERE REFRACTORY CHRONIC IDIOPATHIC URTICARIA
    Song, C.
    Stern, S.
    Maclachlan, S.
    Leader, N.
    Sussman, G. L.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2012, 109 (05) : A36 - A36
12345